Skip to main content
Premium Trial:

Request an Annual Quote

Ingenuity, Atlas Biolabs Ink Software Agreement

Premium

Atlas Biolabs said this week that it has signed a collaborative agreement with Ingenuity Systems so that it can provide its customers with the option to analyze and interpret their study data with Ingenuity's products.

Specifically, customers will have access to Ingenuity Variant Analysis (BI 1/13/2012), which is used to identify causal variants in whole genome and exome sequencing experiments; and iReport which is used to analyze RNA-seq and other gene expression data (BI 1/30/2012).

Both solutions leverage Ingenuity Knowledge Base, which is a repository of biological interactions and functional annotations created from individually modeled relationships between proteins, genes, complexes, cells, tissues, metabolites, drugs, and diseases.

Sean Scott, Ingenuity's senior vice president for global commercial operations, said in a statement that the partnership will provide customers with "a complete sample-to-insight solution" that combines Atlas' lab services with Ingenuity's analysis and biological interpretation solutions.

“The Ingenuity products facilitate and accelerate the bioinformatics support we provide to our customers," Karsten Heidtke, Atlas' head of bioinformatics added.

"They allow us and our customers to interactively maneuver through the data and shed light on it from multiple biological perspectives to understand the biological meaning,” he said.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.